# United Therapeutics

Source: https://onco.cc/companies/united-therapeutics/  
OnCo record `united-therapeutics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

United Therapeutics is a Maryland company known for pulmonary hypertension medicines that also makes dinutuximab (Unituxin), the anti-GD2 antibody that became standard for high-risk neuroblastoma in children.

## Summary

United Therapeutics, founded in 1996 and headquartered in Silver Spring, Maryland, built its business on treatments for pulmonary arterial hypertension and now works on manufactured organs. In oncology it commercialises dinutuximab (Unituxin), the chimeric anti-GD2 antibody developed with the Children's Oncology Group and approved in 2015 for high-risk neuroblastoma after a phase 3 trial showed better event-free survival. ClinicalTrials.gov lists the company as lead sponsor of a phase 3 cancer trial.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: United Therapeutics Corporation; Unither Pharmaceuticals
- Tags: ctgov-sponsor
- HQ: Silver Spring, MD
- Type: biotech
- Website: https://www.unither.com

## Sources

- Official website: https://www.unither.com
- ClinicalTrials.gov: trials led by United Therapeutics Corporation: https://clinicaltrials.gov/search?lead=United%20Therapeutics%20Corporation
- Wikidata: https://www.wikidata.org/wiki/Q21071142

## Connected records

- cancers: [Neuroblastoma (paediatric)](https://onco.cc/cancers/neuroblastoma/)
- drugs: [Dinutuximab (ch14.18) / dinutuximab beta](https://onco.cc/drugs/dinutuximab/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/united-therapeutics.json